Pascal Morel - Concepedia

Author

Pascal Morel

Also Known As

Jean-Laurent Casanova, Marie Metzger, Morel, Pascal, P MOREL, P Morel, P. MOREL, P. Morel, Pascal C. Morel, Pascal Morel, Payton Morel

332

Publications

5.5K

Citations

H-Index

107

Concepts

All Affiliations

Établissement Français du Sang Inserm Centre National de la Recherche Scientifique Assistance Publique – Hôpitaux de Paris Université Claude Bernard Lyon 1

About

Pascal Morel is an author at Établissement Français du Sang specializing in medicine, immunology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	28	1.5K
2	Public Health	4	4	187
3	Engineering	1	1	13
4	Health Sciences	1	1	26
5	Natural Sciences	1	1	55

Pascal Morel

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Paul Bastard, Adrian Gervais, Tom Le Voyer, Science Immunology	2021	600
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Pascal Morel, Mohamed Hebbar, J L Laï, PubMed	1993	303
Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998 Georges Andreu, Pascal Morel, François Forestier, Transfusion	2002	272
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations Ludivine Grzelak, Sarah Temmam, Cyril Planchais, Science Translational Medicine	2020	271
A nationwide survey of hepatitis E viral infection in French blood donors Jean‐Michel Mansuy, Pierre Gallian, Chloé Dimeglio, Hepatology	2016	225
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies Jérémy Manry, Paul Bastard, Adrian Gervais, Proceedings of the National Academy of Sciences Ifn AutoantibodiesImmunologyAge DependentCovid-19Disease Susceptibility	2022	180
Cytogenetics of myelodysplastic syndromes. Pierre Fenaux, Pascal Morel, JL Laï PubMed Hematological MalignancyGeneticsHematologyPathologyMedicine	1996	178
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol Éric Lepage, C Gisselbrecht, Corinne Haïoun, Annals of Oncology Lymphoid NeoplasiaPrognostic EvaluationMedicineMalignant Blood DisorderPrognosis	1993	171
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors Pierre Gallian, Boris Pastorino, Pascal Morel, Antiviral Research VaccinationCovid-19 PandemicImmunologySerologic TestingLower Prevalence	2020	150
Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection Syria Laperche, Nadine Le Marrec, A Girault, Journal of Clinical Microbiology Viral DiagnosticsHepatitis C VirusImmunologyHcv Core AgViral Hepatitis	2005	115

Page 1